Skip to content

Medicare GLP-1 Bridge eligibility checker

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

1. Are you enrolled in Medicare drug coverage (Part D), either a standalone drug plan or a Medicare Advantage plan that includes drug coverage?
2. Is your only Medicare drug coverage through a private fee-for-service plan, a cost contract plan, a health care prepayment plan, a PACE organization, a fallback plan or a religious fraternal benefit plan?
3. Has your Medicare Part D plan paid for a GLP-1 drug for you in 2026, for any reason (for example Ozempic, Rybelsus, Mounjaro, Trulicity, Victoza, Saxenda, Wegovy, Zepbound or Foundayo)?
4. Do you have type 2 diabetes?
5. Do you have moderate to severe obstructive sleep apnea?
6. Have you been diagnosed with MASH (metabolic dysfunction-associated steatohepatitis, a form of fatty liver disease formerly called NASH) with moderate to advanced liver scarring?
7. Is the GLP-1 being prescribed in order to lower your risk of a major cardiovascular event (such as heart attack or stroke) because you have established cardiovascular disease?
8. Are you 18 or older?
9. Is the GLP-1 being prescribed to reduce excess body weight and keep the weight off?
10. Are you using (or will you use) the drug together with a lifestyle program that includes structured nutrition and physical activity?
11. Your BMI when you first started GLP-1 treatment

CMS uses your BMI from when you started treatment, even if it's lower now.

or work it out:

12. Did you have any of these when you started? (counts with a BMI of 30 or higher)
  • heart failure with preserved ejection fraction
  • uncontrolled hypertension (defined as systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg, despite concurrent treatment with two antihypertensive medications)
  • chronic kidney disease stage 3a or above
13. Did you have any of these when you started? (counts with a BMI of 27 or higher)
  • pre-diabetes (as defined by American Diabetes Association guidelines)
  • previous myocardial infarction
  • previous stroke
  • symptomatic peripheral artery disease

Runs in your browser. What you enter stays on your device.

How this works

Every question comes from the eligibility rules CMS and Medicare.gov publish for the Medicare GLP-1 Bridge, including the prior authorization form your prescriber fills in. The checker compares your answers with those rules and gives you one of three results.

  • You may be eligible: your answers meet every published criterion.
  • Not eligible on these answers: one answer doesn't meet a requirement, such as not having Part D or not reaching a BMI tier.
  • Not through the Bridge, but ask your Part D plan: the medicine is for something regular Part D can cover, so CMS sends it through your plan instead.

Each reason comes with CMS's own wording and a link. Your result includes a checklist you can print and take to your prescriber, who sends in the prior authorization. Nothing you answer leaves your browser.

BMI criteria

At the time of initiation of GLP-1 therapy. CMS: "Eligible beneficiaries must meet the clinical criteria at the time of GLP-1 therapy initiation. This includes beneficiaries who initiated therapy prior to enrolling in Medicare Part D and/or prior to the July 1, 2026 launch of the Medicare GLP-1 Bridge."

BMI tiers for the Medicare GLP-1 Bridge
BMI when treatment startedPlus at least one of
35 or higherNo other condition needed
30 or higherheart failure with preserved ejection fraction; uncontrolled hypertension (defined as systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg, despite concurrent treatment with two antihypertensive medications); chronic kidney disease stage 3a or above
27 or higherpre-diabetes (as defined by American Diabetes Association guidelines); previous myocardial infarction; previous stroke; symptomatic peripheral artery disease

Forms the Bridge covers

Bridge copay by medicine and form
MedicineFormCopay per month
FoundayoTablet (once daily)$50
WegovySingle-dose pen (7.2 mg pen is branded WEGOVY HD)$50
WegovyTablet (once daily)$50
ZepboundKwikPen (multi-dose, 4 weekly doses)$50

The Bridge covers Foundayo (tablet), Wegovy (injection or tablet) and Zepbound in the KwikPen only. Single-dose Zepbound vials and single-dose Zepbound pens are not covered, and pen needles for the KwikPen are not covered. CMS says the product list may be updated.

Frequently asked questions

Which GLP-1 drugs does the Medicare Bridge cover?

The Bridge covers Foundayo (tablet), Wegovy (injection or tablet) and Zepbound in the KwikPen only. Single-dose Zepbound vials and single-dose Zepbound pens are not covered, and pen needles for the KwikPen are not covered. CMS says the product list may be updated.

Source

How much does it cost?

You pay a $50 copay for a one-month supply (28 or 30 days, depending on the drug). Because the Bridge runs outside Part D, the $50 does not count toward your Part D deductible or out-of-pocket (TrOOP) costs, Extra Help (the low-income subsidy) does not lower it, it cannot be spread out with the Medicare Prescription Payment Plan, and coupons or discount programs cannot be applied to it.

Source

When does the Medicare GLP-1 Bridge start and end?

The Bridge is a short-term CMS demonstration that runs from July 1, 2026 through December 31, 2027. It is available nationwide, in all states and territories.

Source

What BMI do I need?

You qualify with a BMI of 35 or higher alone, a BMI of 30 or higher plus one listed condition, or a BMI of 27 or higher plus one listed condition. The BMI that counts is the one you had when you first started GLP-1 therapy, even if that was before the Bridge began or before you had Part D, and even if your BMI is lower now. A BMI below 27 does not qualify.

Source

Can I use the Bridge if I have type 2 diabetes?

People with type 2 diabetes are not eligible for the Bridge, whether or not their current Part D plan covers a GLP-1 for it. Part D can cover GLP-1s for this condition, so the request goes to the Part D plan instead.

Source

What if my Part D plan already paid for a GLP-1 this year?

Anyone who has received a GLP-1 through their Part D plan in calendar year 2026 is not eligible for the Bridge and should keep getting the drug through the plan; this also applies to someone who fills through the Bridge and later fills a GLP-1 through Part D. Wording differs by page: Medicare.gov says 'already get' and its checker asks 'have you taken'; the CMS Part D plan page ties the review to calendar year 2026 and says the lookback period for 2027 is not yet determined. A GLP-1 paid for outside Part D (cash, other insurance) is not what this exclusion describes.

Source

Who submits the prior authorization?

Your prescriber, not you, submits the prior authorization (electronically or by fax) after the pharmacy has sent a claim to the Bridge and requested it. The decision is sent to the prescriber and mailed to you within 72 hours of submission. An approval is valid through December 31, 2027 and covers refills and dose changes; a new one is needed only if you switch to a different covered GLP-1. There is no appeals process, but the prescriber can resubmit with corrected or additional information.

Source

Where do I fill the prescription?

Your prescriber sends the prescription to a pharmacy, which bills the Bridge's central processor instead of your Part D plan. Pharmacies do not need to opt in to take part. The pharmacy may ask for your Medicare Number or the last 4 digits of your Social Security Number, and it does not need a denial from your Part D plan first.

Source

What happens after the program ends?

CMS does not say what coverage will exist after December 31, 2027. The only statement on the pages read is that the Bridge was extended through that date ahead of a potential, not confirmed, implementation of the BALANCE Model in Part D.

Source

Sources (6)

  1. 1.
    CMS: Medicare GLP-1 Bridge (information-providers)
    “To qualify for coverage of eligible GLP-1 drugs via the Medicare GLP-1 Bridge, Medicare beneficiaries must be enrolled in a standalone prescription drug plan (PDP) or Medicare Advantage (MA) coordinated care plan (i.e., HMO, HMOPOS, and Local and Regional PPO plans) that offers prescription drug coverage (MA-PD plans) in CY 2026.Part D beneficiaries in Special Needs Plans (SNPs), employer/union group waiver plans (EGWPs), and the Limited Income Newly Eligible Transition (LI NET) program are eligible to participate.”
  2. 2.
    CMS: Medicare GLP-1 Bridge (information-part-d-plans)
    “CMS will review its data to determine whether a patient has previously received a GLP-1 covered by their Part D plan. GLP-1 drugs included in this review include Zepbound, Mounjaro, Foundayo, Rybelsus and Ozempic, Wegovy, Saxenda,Victoza, and Trulicity. If a patient is ineligible for the Medicare GLP-1 Bridge because they have received a GLP-1 through Part D, their pharmacy will receive a notification and can inform the beneficiary. Beneficiaries with questions can reach out to 1-800-MEDICARE for more information. In 2026, CMS will review utilization during Calendar Year 2026. CMS has not yet determined the relevant lookback period that it will apply during 2027.”
  3. 3.
    CMS: Medicare GLP-1 Bridge (glp-1-bridge.pdf)
    “Q3. Does the patient have noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis)[formerly known as nonalcoholic steatohepatitis(NASH)]?”
  4. 4.
    Medicare.gov: weight loss drugs coverage
    “Medicare GLP-1 Bridge is only available to people who are 18 or older.”
  5. 5.
    CMS: Medicare GLP-1 Bridge (medicare-glp-1-bridge)
    “The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027.”
  6. 6.
    CMS: Medicare GLP-1 Bridge (information-pharmacies)
    “Beneficiaries who are approved for coverage under the Medicare GLP-1 Bridge may obtain a single monthly supply (28 or 30 days) of an eligible GLP-1 product per fill. Sixty or ninety-day fills are not available under the Medicare GLP-1 Bridge. Partial fills providing less than a single monthly supply (28 or 30 days) are also not available under the Medicare GLP-1 Bridge.”